F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks

The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.

View original article
Contributor: Pam Belluck